Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AlloStim + Cryoablation in Metastatic Breast Cancer
NCT02018419Phase 2Withdrawn
- Sponsor
- Mirror Biologics, Inc.
- Start
- Mar 2014
- Primary completion
- Mar 2014
- Modality
- Native Immune Cells
- Countries
- 1
01
Overview
A Phase 2 trial of allostim in breast cancer, sponsored by Mirror Biologics, Inc.. Planned start Mar 2014; status: withdrawn.
02
Drugs
allostim
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02018419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02018419.